Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes
Status:
Unknown status
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy of two dosages (600mg/day and 1200mg/day) of bicifadine SR with
placebo for 14 weeks in reduction of chronic neuropathic patin (measured by a daily rating of
pain intensity) associated with diabetic periperal neuropathy in adult outpatients.
To compare the tolerability of two dosages of bicifadine SR with placebo in adult outpaitens
treated for chronic neuropathic pain for 14 weeks associated with diabetic peripheral
neuropathy.